Commentary Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.33696/rehabilitation.5.036
The Interplay of Interferon-Beta, Cobalamin, and MicroRNA Regulation in Multiple Sclerosis Therapy
Nahid Eskandari1, Alireza Andalib1,*
- 1Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Corresponding Author
Alireza Andalib, andalib@med.mui.ac.ir
Received Date: June 11, 2023
Accepted Date: July 14, 2023
Eskandari N, Andalib A. The Interplay of Interferon-Beta, Cobalamin, and MicroRNA Regulation in Multiple Sclerosis Therapy. J Phys Med Rehabil. 2023;5(1):26-27.
Copyright: © 2023 Eskandari N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
miRNAs, Multiple sclerosis, Interferon-Beta, Cobalamin
Recommended Articles
Cutaneous Side Effects of First-Second Line Oral Disease - Modifying Treatments in Patients with Multiple Sclerosis
Multiple sclerosis (MS) is a progressive autoimmune and sometimes disabling disease of the central nervous system (CNS), characterized by formation of white matter lesions in the CNS due to inflammation, demyelination and axonal loss [1-3].
Maintenance of [Met5]-enkephalin Blood Levels Corresponds with a Positive Outcome in Multiple Sclerosis
Multiple sclerosis (MS) is a debilitating disease with a multifactorial etiology that remains to be fully defined. In the United States alone it is estimated that there are one million individuals living with MS.
Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Multiple Sclerosis Lesions: A Time to Peak Analysis
The purpose of the present study was to evaluate, in multiple sclerosis (MS) lesions, the diagnostic performance of two different commercial post-processing MR perfusion software. These two different algorithms for processing Dynamic susceptibility contrast (DSC) perfusion images have been used to differentiate perfusion values among white matter (WM) lesions, normal appearing white matter (NAWM), and grey matter (GM) in MS.
Review of the COVID-19 Risk in Multiple Sclerosis
Severe respiratory syndrome coronavirus-2 (SARSCoV- 2) is the virus responsible for the novel coronavirus disease of 2019 (COVID-19) and has resulted in the death of over one million people around the world. COVID- 19’s presentation is highly heterogeneous as cases range from asymptomatic to rapidly progressive resulting in low survival rates.
The Interplay of Interferon-Beta, Cobalamin, and MicroRNA Regulation in Multiple Sclerosis Therapy
Multiple Sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system, is a complex disorder affecting millions globally, which necessitates innovative therapeutic strategies. In the quest for novel treatments, we have conducted a recent study that has provided crucial insights into the potential synergistic effects of interferonbeta (IFN-β) and cobalamin (Vitamin B12) in MS therapy, targeting interleukin-10 (IL-10), osteopontin (OPN), and specific microRNAs (miR-106a, let-7c, and miR-146a]